Channel Button

There are 6 articles on this title. You are reading the article ranked and rated #3 by Helium's members.

Debate_icon

Politics, News & Issues   >

Political Issues

Get a Widget for this title

Should pharmaceutical companies be required to give up patents necessary to developing a vaccine against pandemic flu?

Title endorsed in part by:

Results so far:

Yes
69% 37 votes Total: 54 votes
No
31% 17 votes

Abstract arguments made regarding intellectual property rights or the necessity of profit to commerce cannot be allowed to trump the lives of actual human beings in the event of a pandemic. Who in their right mind would argue that any corporation's 'right' to make the most profit possible must be protected, although huge portions of the human population will perish to preserve that right? It is precisely in the case of a global pandemic that we best can see the absurdity of basing a health care delivery system on free market fundamentalism.

A pharmaceutical company holding a patent on any precursor or component of a vaccine needed to quell a national or global pandemic ought reasonably to expect that it must be yielded up. Realistically, one cannot argue that any existing pharmaceutical corporation would be bankrupted by that requirement. Other products they sell will quickly recoup the loss, and existing corporations have billions in revenue to absorb adverse circumstances.

This being the case, any argument for the opposing side in this debate must be strictly abstract and academic. There is a place for such arguments, but they are not constructive if human lives are being lost all over the world.

If Big Pharma corporations were truthful, they would admit that a great deal of the research going into the patents they hold is subsidized by either government, governmental agencies, or public universities (which are funded by taxpayer dollars). When those patents strike gold, have any corporations been required to give an appropriate proportion of the profit back to taxpayers? Sadly, no. Although it would seem only fair, lobbyist-controlled legislatures have thus far failed to require that citizens be recompensed for profitable research they have subsidized. One might say Big Pharma owes We the People more than a life-saving patent.

There are times when humanity must decide what is really important, and a global pandemic is one of those times. I do not consider it sane to value corporate profits over the lives of millions, just as I do not consider it rational to ponder the rights and interests of corporations as being equal to the rights and wellbeing of citizens. If one must, for some reason, consider the plight of a multinational pharmaceutical company, one must admit that a decimated pool of actual and potential stockholders cannot be in any corporation's best interest.

Learn more about this author, Lezley Mcdouall.
Contact this writer Click here to send this author comments or questions.


Below are the top articles rated and ranked by Helium members on:

Should pharmaceutical companies be required to give up patents necessary to developing a vaccine against pandemic flu?

Yes
No
  • 1 of 2

    by P. H. Campbell

    Inasmuch as the profit motive in the medical field raises the hackles of those who believe it should be motivated purely

    read more

  • 2 of 2

    by John Knight II

    No.

    The harnessing of the profit incentive, or what some may call greed, is arguably the greatest mechanism for improving

    read more

Add your voice

Know something about Should pharmaceutical companies be required to give up patents necessary to developing a vaccine against pandemic flu??
We want to hear your view. Write_penWrite now!

133415

Featured Partner

Enclave

Enclave is a church in Turlock, California that is exploring what it means to follow Jesus in a rapidly changing cult...more

What is Helium? | Buy Web Content | Contact Us | Privacy | User agreement | DMCA | User Tools | Help | Community | Helium’s Official Blog | Link to Helium

Helium, Inc.
200 Brickstone Square Andover, MA 01810 USA